Blood cancers, Non-Hodgkin lymphoma (NHL)
Results
Phase 2
This trial was for mantle cell lymphoma that has not responded to treatment or had come back. Mantle cell lymphoma is a rare type of non Hodgkin Lymphoma. This trial was supported by Cancer Research UK.
Recruitment start: 20 June 2007
Recruitment end: 6 December 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Simon Rule
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Johnson and Johnson Pharmaceutical R+D
NIHR Clinical Research Network: Cancer
University Hospitals Plymouth NHS Trust
This is Cancer Research UK trial number CRUKE/07/056.
Last reviewed: 23 April 2018
CRUK internal database number: 878